This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Amorepacific Corporation, Dongkook Pharmaceutical Co., Ltd., Other. Active years: 1998-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 562 
1 out of 25 
1 out of 834,570 Years Active: 1998-2011
Title: Innovative Contributions of Inventor Hee-Doo Kim
Introduction
Hee-Doo Kim is a notable inventor based in Seoul, South Korea, renowned for his contributions to pharmaceutical innovations. With a portfolio of 5 patents, Kim has focused primarily on developing compounds that target the vanilloid receptor, which plays a significant role in various neurological and inflammatory conditions.
Latest Patents
Among his most recent inventions, Kim has patented novel compounds, isomers, and pharmaceutically acceptable salts thereof, specifically as vanilloid receptor antagonists. These inventions aim to provide therapeutic solutions for ailments including pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorders, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, respiratory disorders, irritation of the skin, eyes or mucous membranes, stomach-duodenal ulcers, inflammatory diseases, ear diseases, and heart diseases. His work has significant implications for advancing treatment protocols in the medical field.
Career Highlights
Throughout his career, Hee-Doo Kim has collaborated with leading companies in the pharmaceutical industry. Notably, he has worked with Amorepacific Corporation, which has facilitated his research and development efforts. His extensive knowledge and innovative approaches have positioned him as a key player in the field of pharmaceutical inventions.
Collaborations
In his journey as an inventor, Kim has partnered with talented individuals such as Young-Ho Park and Young-Ger Suh, who have contributed to his research projects. These collaborations have fostered a supportive environment for innovation, allowing for the exchange of ideas and expertise in developing effective pharmaceutical solutions.
Conclusion
Hee-Doo Kim continues to be a driving force in the realm of pharmaceutical innovations. With his impressive track record and collaborative spirit, he is poised to make further advancements that can significantly improve the quality of life for patients suffering from various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile